Literature DB >> 2903433

Changes in glutamate-cycle enzyme mRNA levels in a rat model of hepatic encephalopathy.

J W Thomas1, C Banner, J Whitman, K D Mullen, E Freese.   

Abstract

To detect possible changes in the regulation of glutamate/gamma-aminobutyric acid (GABA) enzymes at the level of gene expression in a thioacetamide-induced rat model of acute hepatic encephalopathy, we have examined changes in the mRNAs of four glutamate/GABA enzymes by quantitative RNA blot hybridization analysis. Such changes could reflect cell adaptation to excess ammonia or some other associated metabolic stress. The mRNA levels of glutamate dehydrogenase (GDH) decreased similarly in three different brain regions, whereas those of glutamine synthetase (GS) and glutaminase (GA) increased. The mRNA levels of glutamate decarboxylase (GAD) were unchanged. The results indicate that some effect of liver damage, presumably hyperammonemia, affected the expression of some, but not all, genes associated with ammonia and glutamate metabolism in the brain. This adaptation of gene expression to secondary effects of ammonia on brain amino acid neurotransmitter metabolism or brain energy metabolism could play a role in the physiological changes observed in hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903433     DOI: 10.1007/bf01001011

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  27 in total

1.  Fine structural localization of glutamine synthetase in astrocytes of rat brain.

Authors:  M D Norenberg; A Martinez-Hernandez
Journal:  Brain Res       Date:  1979-02-02       Impact factor: 3.252

2.  Acute metabolic effects of ammonia on the enzymes of glutamate metabolism in isolated astroglial cells.

Authors:  G Y Subbalakshmi; C R Murthy
Journal:  Neurochem Int       Date:  1983       Impact factor: 3.921

3.  Hybridization of oligo(dT) to RNA on nitrocellulose.

Authors:  C B Harley
Journal:  Gene Anal Tech       Date:  1987 Mar-Apr

4.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Thioacetamide-induced hepatic encephalopathy in the rat. I. Preliminary morphological and biochemical observations.

Authors:  W Hilgier; J Albrecht; Z Kraśnicka
Journal:  Neuropatol Pol       Date:  1983

6.  Pathophysiology of ammonia intoxication.

Authors:  W Raabe; S Lin
Journal:  Exp Neurol       Date:  1985-03       Impact factor: 5.330

7.  Immunocytochemical characterization of glutamate dehydrogenase in the cerebellum of the rat.

Authors:  R J Wenthold; R A Altschuler; K K Skaggs; K A Reeks
Journal:  J Neurochem       Date:  1987-02       Impact factor: 5.372

8.  Isolation of a human brain cDNA for glutamate dehydrogenase.

Authors:  C Banner; S Silverman; J W Thomas; K A Lampel; L Vitkovic; D Huie; R J Wenthold
Journal:  J Neurochem       Date:  1987-07       Impact factor: 5.372

9.  The brain octopamine and phenylethanolamine content in rats in thioacetamide-induced hepatogenic encephalopathy.

Authors:  W Hilgier; A Zitting; J Albrecht
Journal:  Acta Neurol Scand       Date:  1985-03       Impact factor: 3.209

10.  Cerebral ammonia metabolism in hyperammonemic rats.

Authors:  A J Cooper; S N Mora; N F Cruz; A S Gelbard
Journal:  J Neurochem       Date:  1985-06       Impact factor: 5.372

View more
  3 in total

1.  Rabbit retinal organ culture as an in-vitro model of hepatic retinopathy.

Authors:  Heidrun Kuhrt; Michał Walski; Andreas Reichenbach; Jan Albrecht
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-18       Impact factor: 3.117

2.  Expression of Glutamate Decarboxylase (GAD) mRNA in the brain of bile duct ligated rats serving as a model of hepatic encephalopathy.

Authors:  Renata Leke; Themis R Silveira; Thayssa D C Escobar; Arne Schousboe
Journal:  Neurochem Res       Date:  2013-08-01       Impact factor: 3.996

Review 3.  Mechanisms, diagnosis and management of hepatic encephalopathy.

Authors:  Ravi Prakash; Kevin D Mullen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.